Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-01-23
1988-10-04
Lee, Mary
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514337, 514444, 546269, 549 60, 549458, A61K 31335, C07D30793
Patent
active
047756926
ABSTRACT:
Disclosed herein are novel prostaglandin I.sub.2 (PGI.sub.2) derivatives exhibiting excellent in vivo duration and activities, said derivatives being represented by the general formula: ##STR1## wherein R.sub.1, X, R.sub.2 and R.sub.3 are as defined herein.
REFERENCES:
patent: 4301164 (1981-11-01), Ohno et al.
patent: 4474802 (1984-10-01), Ohno et al.
patent: 4564620 (1986-01-01), Ohno et al.
Nagase Hiroshi
Nishio Shintaro
Ohno Kiyotaka
Ohtake Atsushi
Takahashi Toshiya
Dentz Bernard I.
Lee Mary
Miller Austin R.
Toray Industries Inc.
LandOfFree
2,5,6,7-tetranor-4,8-inter-m-phenylene PGI.sub.2 derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,5,6,7-tetranor-4,8-inter-m-phenylene PGI.sub.2 derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,5,6,7-tetranor-4,8-inter-m-phenylene PGI.sub.2 derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2156692